1. Home
  2. EYPT vs ACNB Comparison

EYPT vs ACNB Comparison

Compare EYPT & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • ACNB
  • Stock Information
  • Founded
  • EYPT 1987
  • ACNB 1857
  • Country
  • EYPT United States
  • ACNB United States
  • Employees
  • EYPT N/A
  • ACNB N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • ACNB Major Banks
  • Sector
  • EYPT Industrials
  • ACNB Finance
  • Exchange
  • EYPT Nasdaq
  • ACNB Nasdaq
  • Market Cap
  • EYPT 484.4M
  • ACNB 432.5M
  • IPO Year
  • EYPT 2005
  • ACNB N/A
  • Fundamental
  • Price
  • EYPT $10.37
  • ACNB $42.97
  • Analyst Decision
  • EYPT Strong Buy
  • ACNB Strong Buy
  • Analyst Count
  • EYPT 8
  • ACNB 4
  • Target Price
  • EYPT $24.75
  • ACNB $50.00
  • AVG Volume (30 Days)
  • EYPT 817.0K
  • ACNB 23.8K
  • Earning Date
  • EYPT 08-06-2025
  • ACNB 07-23-2025
  • Dividend Yield
  • EYPT N/A
  • ACNB 3.26%
  • EPS Growth
  • EYPT N/A
  • ACNB N/A
  • EPS
  • EYPT N/A
  • ACNB 2.79
  • Revenue
  • EYPT $56,042,000.00
  • ACNB $113,448,000.00
  • Revenue This Year
  • EYPT N/A
  • ACNB $38.67
  • Revenue Next Year
  • EYPT N/A
  • ACNB $5.26
  • P/E Ratio
  • EYPT N/A
  • ACNB $14.96
  • Revenue Growth
  • EYPT 12.04
  • ACNB 8.66
  • 52 Week Low
  • EYPT $3.91
  • ACNB $32.10
  • 52 Week High
  • EYPT $13.99
  • ACNB $50.72
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 72.76
  • ACNB 58.05
  • Support Level
  • EYPT $7.94
  • ACNB $41.65
  • Resistance Level
  • EYPT $10.77
  • ACNB $42.81
  • Average True Range (ATR)
  • EYPT 0.74
  • ACNB 1.04
  • MACD
  • EYPT 0.10
  • ACNB 0.14
  • Stochastic Oscillator
  • EYPT 85.87
  • ACNB 98.95

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

Share on Social Networks: